Kelvin Dhaliwal is a seasoned Key Account Executive at AstraZeneca, where he leverages his extensive experience in the pharmaceutical industry to drive strategic initiatives across multiple therapeutic areas, including ADHD, Respiratory, Diabetes, and Cardiovascular health. His role is pivotal in fostering robust relationships within Secondary...
Kelvin Dhaliwal is a seasoned Key Account Executive at AstraZeneca, where he leverages his extensive experience in the pharmaceutical industry to drive strategic initiatives across multiple therapeutic areas, including ADHD, Respiratory, Diabetes, and Cardiovascular health. His role is pivotal in fostering robust relationships within Secondary Care and the Integrated Care Board Network, where he actively collaborates with healthcare professionals to enhance product and pathway integration. Kelvin's expertise in navigating complex NHS systems has enabled him to successfully manage formulary processes and implement system updates that align with organizational goals, even in instances where formulary inclusion was not initially granted.
Throughout his career, Kelvin has been an integral part of award-winning teams, showcasing his ability to lead and inspire through effective team building and leadership development. His presentations on national platforms highlight not only his deep knowledge of the pharmaceutical landscape but also his commitment to sharing best practices and innovative strategies. By cultivating key stakeholders as brand advocates, Kelvin has significantly contributed to AstraZeneca's mission of improving patient outcomes and advancing healthcare solutions. His proficiency in government relations, sales processes, and project management further solidifies his role as a strategic partner in the healthcare ecosystem, ensuring that AstraZeneca remains at the forefront of industry advancements. With a passion for driving change and a proven track record of success, Kelvin continues to make a meaningful impact in the pharmaceutical sector.
